The discovery of transforming growth factor-α overexpression opened the way of epidermal growth factor receptor blockade with cetuximab as first-line treatment modality for Menetrier's disease.<h4>Case report- ethods</h4>We present the case of a 46-year-old female patient with Menetrier's disease. Here, EGFR is linked to gastric mucosal hypertrophy.